Annals of Clinical and Translational Neurology (Apr 2020)

Clinical validation of an optimized multimodal neurocognitive assessment of chronic mild TBI

  • Mark L. Ettenhofer,
  • Sarah I. Gimbel,
  • Evelyn Cordero

DOI
https://doi.org/10.1002/acn3.51020
Journal volume & issue
Vol. 7, no. 4
pp. 507 – 516

Abstract

Read online

Abstract Objective Previous laboratory‐based studies have shown that neurocognitive eye‐tracking metrics are sensitive to chronic effects of mild traumatic brain injury (mTBI), even in individuals with normal performance on traditional neuropsychological measures. In this study, we sought to replicate and extend these findings in a military medical environment. We expected that metrics from the multimodal Fusion n‐Back test would successfully distinguish chronic mTBI participants from controls, particularly eye movement metrics from the more cognitively challenging “1‐Back” subtest. Methods We compared performance of participants with chronic mTBI (n = 46) and controls (n = 33) on the Fusion n‐Back test and a battery of conventional neuropsychological tests. Additionally, we examined test reliability and the impact of potential confounds to neurocognitive assessment. Results Our results supported hypotheses; Fusion 1‐Back metrics were successful in multimodal (saccadic and manual) classification of chronic mTBI versus control. In contrast, conventional neuropsychological measures could not distinguish these groups. Additional findings demonstrated the reliability of Fusion n‐Back test metrics and provided evidence that saccadic metrics are resistant to confounding influences of age, intelligence, and psychiatric symptoms. Interpretation The Fusion n‐Back test could provide advantages in differential diagnosis for complex brain injury populations. Additionally, the rapid administration of this test could be valuable for screening patients in clinical settings where longer test batteries are not feasible.